Stage IVA Colorectal Cancer Recruiting Phase 1 / 2 Trials for Trifluridine (DB00432)

IndicationStatusPhase
DBCOND0068496 (Stage IVA Colorectal Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03368963TAS102 in Combination With NAL-IRI in Advanced GI CancersTreatment